New York State Common Retirement Fund’s Argos Therapeutics, Inc. ARGS Stock Holding History

New York State Common Retirement Fund’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75	Closed	-$1K	–	3351
2017 Q1	$1K	Hold	75	–	–	﹤0.01%	3138
2016 Q4	$7K	Hold	75	–	–	﹤0.01%	3115
2016 Q3	$7K	Sell	75 -820	-92%	-$85.7K	﹤0.01%	3128
2016 Q2	$110K	Buy	+895	New	+$119K	﹤0.01%	2958
2016 Q1	–	Sell	-436	Closed	-$20K	–	3213
2015 Q4	$20K	Hold	436	–	–	﹤0.01%	3154
2015 Q3	$42K	Hold	436	–	–	﹤0.01%	3128
2015 Q2	$60K	Hold	436	–	–	﹤0.01%	3184
2015 Q1	$78K	Buy	+436	New	+$75.9K	﹤0.01%	2237

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

New York State Common Retirement Fund's ARGS Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2017, closing a stake of 75 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in ARGS in Q1 2015 and held it in 8 quarters. The position peaked at $110K in Q2 2016. 34 funds tracked by Wall St. Rank hold ARGS as of Q2 2017.

New York State Common Retirement Fund reported no remaining Argos Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 75 Argos Therapeutics, Inc. shares in Q2 2017, an estimated $1K.
New York State Common Retirement Fund first reported a position in Argos Therapeutics, Inc. in Q1 2015 and held it in 8 quarters.
New York State Common Retirement Fund's Argos Therapeutics, Inc. position peaked at $110K in Q2 2016.
34 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.